Theodoros and coworkers revealed that CAR-T-therapy-induced CRS was mainly mediated by IL-6, IL-1, and nitric oxide (NO) produced by recipient macrophages, not only CAR-T cells in a SCID-beige murine model of CRS [33]. This evidence concerns the gene IL1B and congenital rubella syndrome.